Measuring the severity of Clostridium difficile infection: implications for management and drug development (Q46215882)

20 December 2017

title

Measuring the severity of Clostridium difficile infection: implications for management and drug development (English)

1 reference

20 December 2017

main subject

Clostridium difficile

object named as

Clostridium difficile

1 reference

2

Dale N Gerding

1 reference

20 December 2017

Jaime Belmares

1

1 reference

20 December 2017

Glenn Tillotson

series ordinal

3

1 reference

20 December 2017

Stuart Johnson

series ordinal

4

1 reference

20 December 2017

publication date

1 December 2008

1 reference

20 December 2017

Expert Review of Anti-infective Therapy

published in

1 reference

20 December 2017

volume

6

1 reference

20 December 2017

issue

6

1 reference

20 December 2017

page(s)

897-908

1 reference

20 December 2017

Fulminant Clostridium difficile colitis

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Emergence of Clostridium difficile-associated disease in North America and Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-rep

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

An epidemic, toxin gene-variant strain of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Severity of Clostridium difficile-associated disease (CDAD) in allogeneic stem cell transplant recipients: evaluation of a CDAD severity grading system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Severe Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Continuation of antibiotics is associated with failure of metronidazole for Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Metronidazole for Clostridium difficile-associated disease: is it okay for Mom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Leukocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Clostridium difficile infection in patients with unexplained leukocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

C-terminal repeats of Clostridium difficile toxin A induce production of chemokine and adhesion molecules in endothelial cells and promote migration of leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Leukemoid reactions complicating colitis due to Clostridium difficile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Clinical and endoscopic findings in patients early in the course of clostridium difficile-associated pseudomembranous colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Colonic abnormalities on CT in adult hospitalized patients with Clostridium difficile colitis: prevalence and significance of findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Clostridium difficile colitis: correlation of CT findings with severity of clinical disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Intensive Care Delirium Screening Checklist: evaluation of a new screening tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Difference in the incidence of Clostridium difficile among patients infected with human immunodeficiency virus admitted to a public hospital and a private hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Clinical recognition and diagnosis of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.897

21 January 2018

Identifiers

DOI

10.1586/14787210.6.6.897

1 reference

20 December 2017

PubMed ID

19053902

1 reference

20 December 2017